Figure 5.
Acute insulin stimulation of ATX secretion is PI3Kinase-dependent and mTOR-independent. 3T3-L1 adipocytes were incubated with media containing 25 mM glucose in the presence or absence of 0 or 100 nM insulin for 6 hours. Where indicated, adipocytes were additionally treated with either 1 µM wortmannin (W), 100 nM rapamycin (R), 10 µg/mL cycloheximide (CHX), or a combination of 5 µg/mL brefeldin A and 5 µM monensin (B/M). (a, b) Cellular ATX (ATX-C) protein expression, (c, d) secreted ATX (ATX-S) protein expression, and (e) activity. Statistical analysis was performed using one-way analysis of variance followed by a Tukey’s multiple comparison test. *P < 0.05; **P < 0.01; ***P < 0.001; ****P < 0.0001 vs untreated controls; ##P < 0.01; ###P < 0.001; ####P < 0.0001 for insulin plus chemical inhibitors vs insulin minus chemical inhibitors; n = 9 from at least three independent experiments. PS, protein stain.

Acute insulin stimulation of ATX secretion is PI3Kinase-dependent and mTOR-independent. 3T3-L1 adipocytes were incubated with media containing 25 mM glucose in the presence or absence of 0 or 100 nM insulin for 6 hours. Where indicated, adipocytes were additionally treated with either 1 µM wortmannin (W), 100 nM rapamycin (R), 10 µg/mL cycloheximide (CHX), or a combination of 5 µg/mL brefeldin A and 5 µM monensin (B/M). (a, b) Cellular ATX (ATX-C) protein expression, (c, d) secreted ATX (ATX-S) protein expression, and (e) activity. Statistical analysis was performed using one-way analysis of variance followed by a Tukey’s multiple comparison test. *P < 0.05; **P < 0.01; ***P < 0.001; ****P < 0.0001 vs untreated controls; ##P < 0.01; ###P < 0.001; ####P < 0.0001 for insulin plus chemical inhibitors vs insulin minus chemical inhibitors; n = 9 from at least three independent experiments. PS, protein stain.

Close
This Feature Is Available To Subscribers Only

Sign In or Create an Account

Close

This PDF is available to Subscribers Only

View Article Abstract & Purchase Options

For full access to this pdf, sign in to an existing account, or purchase an annual subscription.

Close